BillionToOne Overview
- Founded
- 2016
- Status
- Private
- Employees
- 55
- Latest Deal Type
- Series A
- Latest Deal Amount
- $16M
- Investors
- 26
BillionToOne General Information
Description
Developer of a molecular counter platform designed to make molecular diagnostics more accurate, efficient, and accessible for all. The company's prenatal testing procedure focuses on quantitative biology and statistical learning methods to optimize signal-to-noise ratio, thereby making it possible to detect single-gene disorders, enabling expecting mothers to detect disorders such as sickle-cell disease, beta-thalassemia, spinal muscular atrophy, and cystic fibrosis through a simple blood test.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Devices and Supplies
Other Healthcare Services
Primary Office
- 1455 Adams Drive
- Suite 1110
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
BillionToOne Timeline
BillionToOne Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC (Series A) | 25-Feb-2020 | $16M | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A) | 13-Mar-2019 | 0000 | 000.00 | 0000 | Completed | Clinical Trials - General |
| 3. Grant | 01-Jan-2018 | 00000 | 00.00 | Completed | Clinical Trials - General | |
| 2. Seed Round | 30-Sep-2017 | $2.5M | $2.5M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | 22-Aug-2017 | Completed | Pre-Clinical Trials |
BillionToOne Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-6 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Series A-5 | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-4 | 00,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
| Series A-3 | 000,000 | 00.000000 | 00 | 00 | 00 | 00 | 0.000 | |
| Series A-2 | 1,137,210 | $0.000010 | $0.8 | $0.8 | 1x | $0.8 | 5.83% | |
| Series A-1 | 1,349,650 | $0.000010 | $0.4 | $0.4 | 1x | $0.4 | 6.92% |
BillionToOne Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a molecular counter platform designed to make molecular diagnostics more accurate, efficient, and accessibl
Laboratory Services (Healthcare)
Menlo Park, CA
55
As of 2020
000.00
0000
0000-00-00
00000000000
000.00
0000000
tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
000000000000000000 00000000
San Francisco, CA
0000
As of 0000
00000
000000000
00000
00000000
ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000 000000000
Cambridge, MA
0000
As of 0000
00000
00
0000-00-00
00000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialBillionToOne Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Invitae | Formerly VC-backed | San Francisco, CA | 0000 | 00000 | 000000000 | 00000 |
| 0000000000 0000000 | Corporate Backed or Acquired | Cambridge, MA | 0000 | 00000 | 00000000000 | |
| 000000 00000000 | Corporation | Salt Lake City, UT | 0000 | 00000 | 000000 - 000 | 00000 |
| 000000 | Formerly VC-backed | San Carlos, CA | 0000 | 00000 | 000000 - 000 | 00000 |
| 00000000 000000 | Formerly VC-backed | Redwood City, CA | 000 | 00000 | 00000000 | 00000 |
BillionToOne Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Oguzhan Atay Ph.D | Co-Founder, Chief Executive Officer & Chairman | ||
| David Tsao Ph.D | Co-Founder, Chief Technology Officer & Board Member |
BillionToOne Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Tsao Ph.D | BillionToOne | Co-Founder, Chief Technology Officer & Board Member | 000 0000 |
| Firat Ileri | Hummingbird Ventures | Board Member | 000 0000 |
| Oguzhan Atay Ph.D | BillionToOne | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
| Swaroop Kolluri | Neotribe Ventures | Board Member | 000 0000 |
BillionToOne Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBillionToOne Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Libertus Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Enis Hulli | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Henry Senger | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| HOF Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Hummingbird Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |